FDA Approves New Drug for Deadly Lung Cancer, Imdelltra
FRIDAY, MAY 17, 2024 -- The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer.
Importantly, tarlatamab (Imdelltra) is only for patients who have exhausted all other...